Disclosure

Marquee Jv AnnouncedStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+13.8%Reaction day

₹7.24

prior close

₹7.97

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%+10.1% vs market

Pharmaceuticals peers, median of 157sector+2.6%+11.3% vs sector

On the reaction day the stock moved 10.1 pts more than Nifty Microcap 250 and 11.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+1.6

15m

+3.4

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+13.8+3.7+10.1+2.6+11.3

Next day

+7.0+5.1+2.0+2.5+4.5

+12.7+4.0+8.7+1.6+11.1

+3.7+3.2+0.5+1.1+2.6

+3.7+5.9-2.2+2.9+0.8

+6.9+6.9-0.0+3.1+3.8

+0.6+5.9-5.3+2.6-2.0

15d

-0.7+2.1-2.7-0.6-0.1

-17.1-3.5-13.7-2.6-14.6

-3.3-4.2+0.9-4.8+1.5

+4.0+10.9-6.9+4.1-0.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vista Pharmaceuticals has announced a joint venture partnership with Pleiades Therapeutics to jointly develop Generic Drug Products and Specialty Pharmaceutical Products for regulated markets as well as rest-of-the-world (ROW) markets. The collaboration combines Pleiades' R&D expertise with Vista's manufacturing capabilities and marketing presence in the US and other key pharmaceutical markets. The JV is intended to enhance operational capabilities, expand market reach, and strengthen competitive positioning in the global pharma industry. The company has stated that further details regarding the partnership are placed on its corporate website.

Likely market impact

This strategic partnership could open new revenue streams and global market opportunities for Vista Pharmaceuticals, potentially boosting long-term growth, though near-term stock impact will depend on the scale and financial terms of the JV which have not been disclosed yet.